U.S. FDA places clinical hold on BioNTech's malaria vaccine study
BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an ...
Yale Daily News20h
Yale scientists design personalized cancer vaccine
A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...
STAT11h
Wojcicki’s controversial bid to reclaim 23andMe
23andMe CEO Anne Wojcicki is attempting to buy her company back for a mere $42 million. It’s a fraction of the company’s ...
Cancer Vaccine Shows Hope. Make the Investment.
A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the ...
Trump HHS vaccine messaging under scrutiny
Presented by The Coalition to Strengthen America’s Healthcare — Trump administration health secretary Robert F. Kennedy Jr.
The Daily Signal10h
Restoring Trust in Public Health: Play It Straight on Vaccines Effectiveness
The Biden-Harris administration often issued recommendations related to the COVID-19 pandemic that turned out to be false.
RFK Jr.’s Health Department Heightens Scrutiny of Vaccines
The Health and Human Services Department is reviewing contracts and moving to replace vaccine advisers in Robert F. Kennedy ...
BioNTech reports FDA clinical hold on Phase I/IIa trial of BNT165e
In a regulatory filing, BioNTech (BNTX) disclosed that the U.S. Food and Drug Administration has informed BioNTech SE that it has placed a ...